{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:36:00Z","timestamp":1773812160958,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,21]],"date-time":"2014-10-21T00:00:00Z","timestamp":1413849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00228-014-1764-0","type":"journal-article","created":{"date-parts":[[2014,10,20]],"date-time":"2014-10-20T02:14:19Z","timestamp":1413771259000},"page":"35-41","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Clinical features of and genetic predisposition to drug-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients\u2014investigating the relation between the HLA -B*4403 allele and lamotrigine"],"prefix":"10.1007","volume":"71","author":[{"given":"Hye Jung","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Ryeol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Woo","family":"Leem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Il Joo","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beom Seok","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,21]]},"reference":[{"issue":"6","key":"1764_CR1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/eci.11.66","volume":"7","author":"M Mockenhaupt","year":"2011","unstructured":"Mockenhaupt M (2011) The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol 7(6):803\u2013813. doi: 10.1586\/eci.11.66 , quiz 814-805","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"1764_CR2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","volume":"138","author":"A Auquier-Dunant","year":"2002","unstructured":"Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC, Reactions SSGSCA (2002) Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 138(8):1019\u20131024","journal-title":"Arch Dermatol"},{"issue":"8","key":"1764_CR3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.autrev.2008.06.004","volume":"7","author":"AT Borchers","year":"2008","unstructured":"Borchers AT, Lee JL, Naguwa SM, Cheema GS, Gershwin ME (2008) Stevens-Johnson syndrome and toxic epidermal necrolysis. Autoimmun Rev 7(8):598\u2013605. doi: 10.1016\/j.autrev.2008.06.004","journal-title":"Autoimmun Rev"},{"issue":"6","key":"1764_CR4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archderm.1991.01680050083008","volume":"127","author":"E Schopf","year":"1991","unstructured":"Schopf E, Stuhmer A, Rzany B, Victor N, Zentgraf R, Kapp JF (1991) Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol 127(6):839\u2013842","journal-title":"Arch Dermatol"},{"issue":"19","key":"1764_CR5","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","volume":"331","author":"JC Roujeau","year":"1994","unstructured":"Roujeau JC, Stern RS (1994) Severe adverse cutaneous reactions to drugs. N Engl J Med 331(19):1272\u20131285. doi: 10.1056\/NEJM199411103311906","journal-title":"N Engl J Med"},{"issue":"2","key":"1764_CR6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1600-0404.1990.tb00949.x","volume":"81","author":"H Askmark","year":"1990","unstructured":"Askmark H, Wiholm BE (1990) Epidemiology of adverse reactions to carbamazepine as seen in a spontaneous reporting system. Acta Neurol Scand 81(2):131\u2013140","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"1764_CR7","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archderm.1991.01680050075007","volume":"127","author":"BL Strom","year":"1991","unstructured":"Strom BL, Carson JL, Halpern AC, Schinnar R, Snyder ES, Shaw M, Tilson HH, Joseph M, Dai WS, Chen D et al (1991) A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures. Arch Dermatol 127(6):831\u2013838","journal-title":"Arch Dermatol"},{"issue":"8","key":"1764_CR8","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/archderm.1990.01670320127028","volume":"126","author":"L Naldi","year":"1990","unstructured":"Naldi L, Locati F, Marchesi L, Cainelli T (1990) Incidence of toxic epidermal necrolysis in Italy. Arch Dermatol 126(8):1103\u20131104","journal-title":"Arch Dermatol"},{"issue":"1","key":"1764_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2332\/allergolint.55.27","volume":"55","author":"JC Roujeau","year":"2006","unstructured":"Roujeau JC (2006) Immune mechanisms in drug allergy. Allergol Int Off J Jpn Soc Allergol 55(1):27\u201333. doi: 10.2332\/allergolint.55.27","journal-title":"Allergol Int Off J Jpn Soc Allergol"},{"issue":"6982","key":"1764_CR10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"WH Chung","year":"2004","unstructured":"Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT (2004) Medical genetics: a marker for Stevens-Johnson syndrome. Nature 428(6982):486. doi: 10.1038\/428486a","journal-title":"Nature"},{"issue":"12","key":"1764_CR11","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","volume":"49","author":"C Locharernkul","year":"2008","unstructured":"Locharernkul C, Loplumlert J, Limotai C, Korkij W, Desudchit T, Tongkobpetch S, Kangwanshiratada O, Hirankarn N, Suphapeetiporn K, Shotelersuk V (2008) Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia 49(12):2087\u20132091. doi: 10.1111\/j.1528-1167.2008.01719.x","journal-title":"Epilepsia"},{"issue":"6","key":"1764_CR12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4103\/0378-6323.57718","volume":"75","author":"TY Mehta","year":"2009","unstructured":"Mehta TY, Prajapati LM, Mittal B, Joshi CG, Sheth JJ, Patel DB, Dave DM, Goyal RK (2009) Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians. Indian J Dermatol Venereol Leprology 75(6):579\u2013582. doi: 10.4103\/0378-6323.57718","journal-title":"Indian J Dermatol Venereol Leprology"},{"issue":"5","key":"1764_CR13","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1528-1167.2010.02533.x","volume":"51","author":"W Tassaneeyakul","year":"2010","unstructured":"Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Chen P, Lin SY, Chen WH, Konyoung P, Khunarkornsiri U, Auvichayapat N, Pavakul K, Kulkantrakorn K, Choonhakarn C, Phonhiamhan S, Piyatrakul N, Aungaree T, Pongpakdee S, Yodnopaglaw P (2010) Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. Epilepsia 51(5):926\u2013930. doi: 10.1111\/j.1528-1167.2010.02533.x","journal-title":"Epilepsia"},{"issue":"2","key":"1764_CR14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-4632.2010.04745.x","volume":"50","author":"CC Chang","year":"2011","unstructured":"Chang CC, Too CL, Murad S, Hussein SH (2011) Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population. Int J Dermatol 50(2):221\u2013224. doi: 10.1111\/j.1365-4632.2010.04745.x","journal-title":"Int J Dermatol"},{"issue":"6","key":"1764_CR15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.seizure.2011.02.003","volume":"20","author":"Q Wang","year":"2011","unstructured":"Wang Q, Zhou JQ, Zhou LM, Chen ZY, Fang ZY, Chen SD, Yang LB, Cai XD, Dai QL, Hong H, Wang HX (2011) Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland. Seizure J Br Epilepsy Assoc 20(6):446\u2013448. doi: 10.1016\/j.seizure.2011.02.003","journal-title":"Seizure J Br Epilepsy Assoc"},{"issue":"10","key":"1764_CR16","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2217\/14622416.9.10.1543","volume":"9","author":"PB Ferrell Jr","year":"2008","unstructured":"Ferrell PB Jr, McLeod HL (2008) Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics 9(10):1543\u20131546. doi: 10.2217\/14622416.9.10.1543","journal-title":"Pharmacogenomics"},{"issue":"10","key":"1764_CR17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1346-8138.2008.00548.x","volume":"35","author":"M Kashiwagi","year":"2008","unstructured":"Kashiwagi M, Aihara M, Takahashi Y, Yamazaki E, Yamane Y, Song Y, Muramatsu M, Ikezawa Z (2008) Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients. J Dermatol 35(10):683\u2013685. doi: 10.1111\/j.1346-8138.2008.00548.x","journal-title":"J Dermatol"},{"issue":"12","key":"1764_CR18","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/j.1528-1167.2010.02766.x","volume":"51","author":"N Kaniwa","year":"2010","unstructured":"Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, Furuya H, Takahashi Y, Muramatsu M, Kinoshita S, Abe M, Ikeda H, Kashiwagi M, Song Y, Ueta M, Sotozono C, Ikezawa Z, Hasegawa R, JSAR research group (2010) HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Epilepsia 51(12):2461\u20132465. doi: 10.1111\/j.1528-1167.2010.02766.x","journal-title":"Epilepsia"},{"issue":"5","key":"1764_CR19","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/hmg\/ddq537","volume":"20","author":"T Ozeki","year":"2011","unstructured":"Ozeki T, Mushiroda T, Yowang A, Takahashi A, Kubo M, Shirakata Y, Ikezawa Z, Iijima M, Shiohara T, Hashimoto K, Kamatani N, Nakamura Y (2011) Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum Mol Genet 20(5):1034\u20131041. doi: 10.1093\/hmg\/ddq537","journal-title":"Hum Mol Genet"},{"issue":"1\u20132","key":"1764_CR20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.eplepsyres.2011.08.010","volume":"97","author":"SH Kim","year":"2011","unstructured":"Kim SH, Lee KW, Song WJ, Kim SH, Jee YK, Lee SM, Kang HR, Park HW, Cho SH, Park SH, Min KU, Chang YS, Adverse Drug Reaction Research Group in K (2011) Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans. Epilepsy Res 97(1\u20132):190\u2013197. doi: 10.1016\/j.eplepsyres.2011.08.010","journal-title":"Epilepsy Res"},{"issue":"Suppl 7","key":"1764_CR21","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1111\/j.1528-1157.1998.tb01681.x","volume":"39","author":"RG Schlienger","year":"1998","unstructured":"Schlienger RG, Shapiro LE, Shear NH (1998) Lamotrigine-induced severe cutaneous adverse reactions. Epilepsia 39(Suppl 7):S22\u2013S26","journal-title":"Epilepsia"},{"issue":"5","key":"1764_CR22","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4103\/0019-5154.117319","volume":"58","author":"S Kaur","year":"2013","unstructured":"Kaur S, Dogra A (2013) Toxic epidermal necrolysis due to concomitant use of lamotrigine and valproic acid. Indian J Dermatol 58(5):406. doi: 10.4103\/0019-5154.117319","journal-title":"Indian J Dermatol"},{"issue":"1","key":"1764_CR23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129(1):92\u201396","journal-title":"Arch Dermatol"},{"issue":"1","key":"1764_CR24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/BCR.0b013e31815f3865","volume":"29","author":"R Cartotto","year":"2008","unstructured":"Cartotto R, Mayich M, Nickerson D, Gomez M (2008) SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center. J Burn Care Res 29(1):141\u2013146. doi: 10.1097\/Bcr.0b013e31815f3865","journal-title":"J Burn Care Res"},{"issue":"2","key":"1764_CR25","doi-asserted-by":"crossref","first-page":"187 e1","DOI":"10.1016\/j.jaad.2013.05.002","volume":"69","author":"RA Schwartz","year":"2013","unstructured":"Schwartz RA, McDonough PH, Lee BW (2013) Toxic epidermal necrolysis: part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment. J Am Acad Dermatol 69(2):187 e1\u2013187.e16. doi: 10.1016\/j.jaad.2013.05.002 , quiz 203\u2013184","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1764_CR26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","volume":"115","author":"S Bastuji-Garin","year":"2000","unstructured":"Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P (2000) SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Investig Dermatol 115(2):149\u2013153. doi: 10.1046\/j.1523-1747.2000.00061.x","journal-title":"J Investig Dermatol"},{"issue":"7","key":"1764_CR27","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archderm.140.7.890","volume":"140","author":"JT Trent","year":"2004","unstructured":"Trent JT, Kirsner RS, Romanelli P, Kerdel FA (2004) Use of SCORTEN to accurately predict mortality in patients with toxic epidermal necrolysis in the United States. Arch Dermatol 140(7):890\u2013892. doi: 10.1001\/archderm.140.7.890","journal-title":"Arch Dermatol"},{"key":"1764_CR28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-61779-842-9_4","volume":"882","author":"D Trajanoski","year":"2012","unstructured":"Trajanoski D, Fidler SJ (2012) HLA typing using bead-based methods. Methods Mol Biol 882:47\u201365. doi: 10.1007\/978-1-61779-842-9_4","journal-title":"Methods Mol Biol"},{"issue":"2","key":"1764_CR29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3904\/kjim.2012.27.2.203","volume":"27","author":"HI Kim","year":"2012","unstructured":"Kim HI, Kim SW, Park GY, Kwon EG, Kim HH, Jeong JY, Chang HH, Lee JM, Kim NS (2012) Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients. Korean J Intern Med 27(2):203\u2013210. doi: 10.3904\/kjim.2012.27.2.203","journal-title":"Korean J Intern Med"},{"issue":"2","key":"1764_CR30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4168\/aair.2010.2.2.123","volume":"2","author":"YJ Jeung","year":"2010","unstructured":"Jeung YJ, Lee JY, Oh MJ, Choi DC, Lee BJ (2010) Comparison of the causes and clinical features of drug rash with eosinophilia and systemic symptoms and Stevens-Johnson syndrome. Allergy Asthma Immunol Res 2(2):123\u2013126. doi: 10.4168\/aair.2010.2.2.123","journal-title":"Allergy Asthma Immunol Res"},{"issue":"6","key":"1764_CR31","doi-asserted-by":"crossref","first-page":"792","DOI":"10.4103\/0253-7613.103304","volume":"44","author":"A Saha","year":"2012","unstructured":"Saha A, Das NK, Hazra A, Gharami RC, Chowdhury SN, Datta PK (2012) Cutaneous adverse drug reaction profile in a tertiary care out patient setting in eastern India. Indian J Pharmacol 44(6):792\u2013797. doi: 10.4103\/0253-7613.103304","journal-title":"Indian J Pharmacol"},{"issue":"5","key":"1764_CR32","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2230.2006.02185.x","volume":"31","author":"LF Li","year":"2006","unstructured":"Li LF, Ma C (2006) Epidemiological study of severe cutaneous adverse drug reactions in a city district of China. Clin Exp Dermatol 31(5):642\u2013647. doi: 10.1111\/j.1365-2230.2006.02185.x","journal-title":"Clin Exp Dermatol"},{"issue":"7","key":"1764_CR33","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.clineuro.2012.01.019","volume":"114","author":"XQ Wang","year":"2012","unstructured":"Wang XQ, Lang SY, Shi XB, Tian HJ, Wang RF, Yang F (2012) Antiepileptic drug-induced skin reactions: a retrospective study and analysis in 3793 Chinese patients with epilepsy. Clin Neurol Neurosurg 114(7):862\u2013865. doi: 10.1016\/j.clineuro.2012.01.019","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"1764_CR34","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.jaci.2011.12.990","volume":"129","author":"CY Wei","year":"2012","unstructured":"Wei CY, Chung WH, Huang HW, Chen YT, Hung SI (2012) Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome. J Allergy Clin Immunol 129(6):1562\u20131569 e1565. doi: 10.1016\/j.jaci.2011.12.990","journal-title":"J Allergy Clin Immunol"},{"issue":"7404","key":"1764_CR35","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","volume":"486","author":"PT Illing","year":"2012","unstructured":"Illing PT, Vivian JP, Dudek NL, Kostenko L, Chen Z, Bharadwaj M, Miles JJ, Kjer-Nielsen L, Gras S, Williamson NA, Burrows SR, Purcell AW, Rossjohn J, McCluskey J (2012) Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 486(7404):554\u2013558. doi: 10.1038\/nature11147","journal-title":"Nature"},{"issue":"25","key":"1764_CR36","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.1207934109","volume":"109","author":"DA Ostrov","year":"2012","unstructured":"Ostrov DA, Grant BJ, Pompeu YA, Sidney J, Harndahl M, Southwood S, Oseroff C, Lu S, Jakoncic J, de Oliveira CA, Yang L, Mei H, Shi L, Shabanowitz J, English AM, Wriston A, Lucas A, Phillips E, Mallal S, Grey HM, Sette A, Hunt DF, Buus S, Peters B (2012) Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc Natl Acad Sci U S A 109(25):9959\u20139964. doi: 10.1073\/pnas.1207934109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1764_CR37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.yebeh.2010.08.007","volume":"19","author":"XT Wu","year":"2010","unstructured":"Wu XT, Hu FY, An DM, Yan B, Jiang X, Kwan P, Stefan H, Zhou D (2010) Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China. Epilepsy Behav: E&B 19(3):405\u2013408. doi: 10.1016\/j.yebeh.2010.08.007","journal-title":"Epilepsy Behav: E&B"},{"issue":"12","key":"1764_CR38","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","volume":"364","author":"M McCormack","year":"2011","unstructured":"McCormack M, Alfirevic A, Bourgeois S, Farrell JJ, Kasperaviciute D, Carrington M, Sills GJ, Marson T, Jia X, de Bakker PI, Chinthapalli K, Molokhia M, Johnson MR, O\u2019Connor GD, Chaila E, Alhusaini S, Shianna KV, Radtke RA, Heinzen EL, Walley N, Pandolfo M, Pichler W, Park BK, Depondt C, Sisodiya SM, Goldstein DB, Deloukas P, Delanty N, Cavalleri GL, Pirmohamed M (2011) HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med 364(12):1134\u20131143. doi: 10.1056\/NEJMoa1013297","journal-title":"N Engl J Med"},{"issue":"5","key":"1764_CR39","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1399-0039.2005.00386.x","volume":"65","author":"KW Lee","year":"2005","unstructured":"Lee KW, Oh DH, Lee C, Yang SY (2005) Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population. Tissue Antigens 65(5):437\u2013447. doi: 10.1111\/j.1399-0039.2005.00386.x","journal-title":"Tissue Antigens"},{"issue":"8","key":"1764_CR40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.gene.6363890","volume":"3","author":"M Sato","year":"2002","unstructured":"Sato M, Ohashi J, Tsuchiya N, Kashiwase K, Ishikawa Y, Arita H, Hanaoka K, Tokunaga K, Yabe T (2002) Association of HLA-A*3303-B*4403-DRB1*1302 haplotype, but not of TNFA promoter and NKp30 polymorphism, with postherpetic neuralgia (PHN) in the Japanese population. Genes Immun 3(8):477\u2013481. doi: 10.1038\/sj.gene.6363890","journal-title":"Genes Immun"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-014-1764-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-014-1764-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-014-1764-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T10:19:26Z","timestamp":1565950766000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-014-1764-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,21]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["1764"],"URL":"https:\/\/doi.org\/10.1007\/s00228-014-1764-0","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,21]]}}}